Morgan E. Obrien - Dec 9, 2024 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Executive Chairman, Director
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Stock symbol
ATEX
Transactions as of
Dec 9, 2024
Transactions value $
-$351,114
Form type
4
Date filed
12/11/2024, 08:31 PM
Previous filing
May 22, 2023
Next filing
Dec 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATEX Common Stock Options Exercise $2.25M +90K +375.42% $25.00 114K Dec 9, 2024 Direct
transaction ATEX Common Stock Tax liability -$2.6M -76.4K -67.03% $34.05 37.6K Dec 9, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Options Exercise $0 -90K -100% $0.00 0 Dec 9, 2024 Common Stock 90K $25.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This price reflects the closing price of the Issuer's Common Stock on the Nasdaq Capital Market on December 9, 2024.
F2 The option shares are fully vested and the option would have expired by its terms on January 29, 2025.